Clindamycin hydrochloride, randomly labeled with tritium, was synthesized and used for animal metabolism studies. The drug was administered to rats (oral and intraperitoneal routes) and dogs (oral and intramuscular routes) at a dose of 50-150 mg./ kg. In both species, after the oral or parenteral dr
Absorption, metabolism, and excretion of salicylic phenolic glucuronidc in rats
โ Scribed by Gerha. Rd Levy; Leonard Weintraub; Tai Matsuzawa; Stanley R. Oles
- Publisher
- John Wiley and Sons
- Year
- 1966
- Tongue
- English
- Weight
- 192 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
โฆ Synopsis
Salicylic phenolic glucuronide is excreted rapidly by apparent first-order kinetics (t>a about 0.7 hr.) after intravenous administration to adult rats. Only a small fraction of an injected dose is hydrolyzed in vim to salicylic acid. The glucuronide is apparently not absorbed significantly as such from the gastrointestinal tract. Part o f an orally administered dose is absorbed apparently from the lower region of the intestinal tract after hydrolysis to salicylic acid.
IIE PHAKMACOKINETICS of elimination of sali-T cylic acid and its major Irietdbolite, salicyluric acid, have been studied in some detail in man and rats (lL4). Much less is known about the kinetics of elimination of salicylic phenolic glucuronidc, another irrilportarit rnetabolitc of salicylic acid.' This glucur,onidc has been prepared in pure form and (since technical problems did not permit its intravenous administration to man) its absorption, metabolism, and excretion have. been studicd in rats.
A previous study has shown that the pharrnacokinetics of salicylate elimination in man and rats :ire quite similar (4).
EXPERIMENTAL
Synthesis of Salicylic Phenolic G1ucuronide.-Methyl (tr:i-O-acetyl-ol-D-glucopy~dnosyl bromide) uronatc: was prepared from glucuronolactone by the procedure of Bollenback et ul. (6). From it, ocarboxypheriyl-P-D-glucopyranosiduronic acid (salicylic phenolic glucuronide) was obtained by methods described by Lunsford and Murphey (7), m.p. 144.5-146'.
๐ SIMILAR VOLUMES
35S-Furosemide was administered to beagle dogs and rhesus monkeys in an oral solution on a single and a 20 repeated 5-mg/kg/day dosing regimen. Following the single dose, 25.0% (dogs) and 24.0% (monkeys) of the dose were excreted in the urine in 24 hr. TLC analysis demonstrated that both species had